Health Canada Approves ZEPOSIA®, an Oral Treatment for Relapsing Remitting Multiple Sclerosis Biotech Investing
Opdivo Plus Chemotherapy Shows Statistically Significant Improvement in Pathologic Complete Response as Neoadjuvant Treatment of Resectable Non-Small Cell Lung Cancer in Phase 3 CheckMate -816 Trial Biotech Investing
BriaCell to Present Clinical Findings at the 2020 San Antonio Breast Cancer Symposium®, December 9 - 11 Biotech Investing
Amgen Announces Positive Topline Phase 2 Results For Investigational KRAS G12C Inhibitor Sotorasib In Advanced Non-Small Cell Lung Cancer Biotech Investing
Alert: Johnson Fistel Investigates Proposed Sale of MyoKardia; Is $225 a Fair Price? Biotech Investing
Trillium Therapeutics Receives Notices of Allowance From U.S. Patent and Trademark Office Biotech Investing
Gilead Presents Biktarvy® Findings From Switch Studies & Analysis of Real-World BICSTaR Study At HIV Glasgow 2020 Biotech Investing
Amgen Announces Five-Year Data That Reinforce The Safety And Efficacy Profile Of Aimovig® In Adult Patients With Episodic Migraine Biotech Investing
